Skip to content
IP + Technology Law
Home  »  News & Insights  »  Presentation

Strategies for Taking Advantage of the America Invents Act: Resolving the Tension Between Patentable Subject Matter & Joint Infringement | Presentations

November 6, 2012  | Irfan Lateef, Dan Altman and Kerry S. Taylor, Ph.D.

Knobbe Martens Partners recently gave a seminar titled “Strategies for Taking Advantage of the America Invents Act, Resolving the Tension Between Patentable Subject Matter & Joint Infringement” in Tokyo, Japan to discuss various intellectual property issues affecting high tech and biotech companies.

The presentations below have been made available for reference to the topics that were covered. 

Supplemental Examination Under the AIA from Knobbe Martens Olson & Bear

Patentable Subject Matter in the United States from Knobbe Martens Olson & Bear

Patentable Subject Matter in Biotechnology from Knobbe Martens Olson & Bear

Patent Eligible Subject Matter and High Tech Inventions from Knobbe Martens Olson & Bear

Joint Infringement Issues During Litigation and Prosecution from Knobbe Martens Olson & Bear

An Introduction to Derivation Proceedings from Knobbe Martens Olson & Bear

Changes in Examination Under the America Invents Act from Knobbe Martens Olson & Bear

Post Issuance Inter Partes Disputes: What You Need to Know from Knobbe Martens Olson & Bear
Strategies for Taking Advantage of the America Invents Act: Resolving the Tension Between Patentable Subject Matter & Joint Infringement | Presentations Headshot

Irfan Lateef
Partner
Orange County
irfan.lateef@knobbe.com
949-760-0404
Strategies for Taking Advantage of the America Invents Act: Resolving the Tension Between Patentable Subject Matter & Joint Infringement | Presentations Headshot

Dan Altman
Partner
Orange County
dan.altman@knobbe.com
949-760-0404

Related Links

Practice Areas

Industries

News & Insights

Publications
Mar 2026
USPTO Director to Consider U.S. Manufacturing and Small Business Status When Instituting or Denying IPR and PGR Petitions
Key Takeaways Effective immediately, the USPTO will consider whether a patent challenger’s accused products or a patent owner’s products are manufactured in the United States as additional factors in the...
Blog - Biotechnology
Mar 2026
IP Considerations Following FDA Announcement on Flexibility for Cell and Gene Therapies
Key Takeaways: Manufacturing processes of cell and gene therapies (CGTs) may remain fluid well into development and even after FDA approval, and therefore sponsors of CGTs may benefit from patent...
Blog - Aerospace
Mar 2026
War in Iran Spotlights Innovation for Missile Interception Startups
Key Takeaways: The war in Iran is likely to accelerate innovation for defense technology companies. Innovation is particularly needed to develop low-cost missile interception technology. While established defense technology companies...